Delivery Order SPE2DB22D9205-SPE2DB25FZF98

Award Date 3/24/25
Potential Completion Date 4/14/25
Potential Value $6.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,943.10, is for the delivery of 68 mg NEXPLANON implants, a contraceptive device. The contract is a firm fixed-price delivery order with a period of performance through March 13, 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $5,717.52 firm-fixed-price contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive implant product. The contract has an ultimate completion date of April 5, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery vehicle (IDV) contract, SPE2DB, with DLA valued up to $4,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,007.82, is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive implant. The contract is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,837.40 contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a type of contraceptive implant, with a completion date of October 18, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $33,326.88 firm fixed-price contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a type of contraceptive device, with a performance period through March 31, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive implant, at a firm fixed price of $14,293.80. The contract has a completion date of March 26, 2024. DMS Pharmaceutical Group holds a larger Indefinite Delivery Vehicle (IDV) contract with the DLA, valued up...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,943.10 contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a specialized contraceptive product, with a period of performance through March 18, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,943.10 contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive product, with a completion date of February 7, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $21,440.70 firm fixed-price contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a branded contraceptive product, with a period of performance through December 26, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,152.56 firm fixed-price contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive product, with a performance period through May 22, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
  • SPE2DB22D9205
    Indefinite Delivery Contract
  • SPE2DB22D9205-SPE2DB25FZF98
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,943.10, is for the procurement of NEXPLANON 68 MG IMPLANTS, a contraceptive product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 14, 2025.

DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide.

Generated 6/29/25, 1:18 AM